– Toripalimab plus chemotherapy resulted in a 37% reduction in the risk of death, HR=0.63, versus chemotherapy alone, in nasopharyngeal carcinoma patients.
– Toripalimab plus chemotherapy resulted in a 37% reduction in the risk of death, HR=0.63, versus chemotherapy alone, in nasopharyngeal carcinoma patients – – No treatments are. | June 5, 2023
LIVED TO TELL THE TALE Rob Paulsen is back behind the microphone following his battle with throat cancer. Courtesy photo For many people, talking to Rob Paulsen is essentially like speaking with beloved figures from childhood. They may never have met him, but they grew up listening to his voice. Paulsen a longtime resident of Agoura Hills is
(BPT) - As a successful global software services consultant, Ashwin was career-driven and passionate about his job. Those feelings were derailed when, at age 45, he was diagnosed with head